University of Alabama at Birmingham, 1720 2nd Ave South — Birmingham, Alabama

University of Alabama at Birmingham, 1720 2nd Ave South is a clinical research site located in Birmingham, Alabama, United States 35294-3412.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Alabama at Birmingham, 1720 2nd Ave South has participated in 1 clinical trials.

Therapeutic areas: Primary IgA Nephropathy.

Sponsors: Calliditas Therapeutics AB.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Alabama at Birmingham, 1720 2nd Ave South?

University of Alabama at Birmingham, 1720 2nd Ave South has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Alabama at Birmingham, 1720 2nd Ave South conducted?

University of Alabama at Birmingham, 1720 2nd Ave South has 1 clinical trials on record. Their work covers Primary IgA Nephropathy.

Is University of Alabama at Birmingham, 1720 2nd Ave South accredited by Crixeo Health?

University of Alabama at Birmingham, 1720 2nd Ave South has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Alabama at Birmingham, 1720 2nd Ave South?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.